ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Glucocerebrosidase Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-22J18258
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Glucocerebrosidase Market Research Report 2024
BUY CHAPTERS

Global Recombinant Glucocerebrosidase Market Research Report 2024

Code: QYRE-Auto-22J18258
Report
October 2024
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Takeda Pharmaceuticals
Sanofi
ISU ABXIS
Protalix Biotherapeutics

Recombinant Glucocerebrosidase Market

Recombinant glucocerebrosidase is an engineered enzyme produced using recombinant DNA technology, aimed at treating Gaucher's disease, a genetic disorder caused by the deficiency of the natural enzyme. This therapy helps break down glucocerebroside, a fatty substance that accumulates in cells, alleviating symptoms and improving patient quality of life.
The global Recombinant Glucocerebrosidase market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Recombinant Glucocerebrosidase is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Glucocerebrosidase is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Recombinant Glucocerebrosidase include Pfizer, Takeda Pharmaceuticals, Sanofi, ISU Abxis, Protalix Biotherapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Glucocerebrosidase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Glucocerebrosidase.
The Recombinant Glucocerebrosidase market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Recombinant Glucocerebrosidase market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Glucocerebrosidase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Glucocerebrosidase Market Report

Report Metric Details
Report Name Recombinant Glucocerebrosidase Market
Segment by Type
Segment by Application
  • Hospital and Clinic
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Takeda Pharmaceuticals, Sanofi, ISU Abxis, Protalix Biotherapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Glucocerebrosidase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Glucocerebrosidase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Recombinant Glucocerebrosidase Market report?

Ans: The main players in the Recombinant Glucocerebrosidase Market are Pfizer, Takeda Pharmaceuticals, Sanofi, ISU Abxis, Protalix Biotherapeutics

What are the Application segmentation covered in the Recombinant Glucocerebrosidase Market report?

Ans: The Applications covered in the Recombinant Glucocerebrosidase Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the Recombinant Glucocerebrosidase Market report?

Ans: The Types covered in the Recombinant Glucocerebrosidase Market report are Imiglucerase, Velaglucerase Alfa, Taliglucerase Alfa

Recommended Reports

Recombinant Proteins

Enzyme Drug Therapy

Rare Disease Treatment

1 Recombinant Glucocerebrosidase Market Overview
1.1 Product Definition
1.2 Recombinant Glucocerebrosidase by Type
1.2.1 Global Recombinant Glucocerebrosidase Market Value Comparison by Type (2024-2030)
1.2.2 Imiglucerase
1.2.3 Velaglucerase Alfa
1.2.4 Taliglucerase Alfa
1.3 Recombinant Glucocerebrosidase by Application
1.3.1 Global Recombinant Glucocerebrosidase Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Recombinant Glucocerebrosidase Market Size Estimates and Forecasts
1.4.1 Global Recombinant Glucocerebrosidase Revenue 2019-2030
1.4.2 Global Recombinant Glucocerebrosidase Sales 2019-2030
1.4.3 Global Recombinant Glucocerebrosidase Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Glucocerebrosidase Market Competition by Manufacturers
2.1 Global Recombinant Glucocerebrosidase Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Glucocerebrosidase Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Glucocerebrosidase Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Recombinant Glucocerebrosidase, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Glucocerebrosidase, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Glucocerebrosidase, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Glucocerebrosidase, Date of Enter into This Industry
2.8 Global Recombinant Glucocerebrosidase Market Competitive Situation and Trends
2.8.1 Global Recombinant Glucocerebrosidase Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Glucocerebrosidase Players Market Share by Revenue
2.8.3 Global Recombinant Glucocerebrosidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Glucocerebrosidase Market Scenario by Region
3.1 Global Recombinant Glucocerebrosidase Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Glucocerebrosidase Sales by Region: 2019-2030
3.2.1 Global Recombinant Glucocerebrosidase Sales by Region: 2019-2024
3.2.2 Global Recombinant Glucocerebrosidase Sales by Region: 2025-2030
3.3 Global Recombinant Glucocerebrosidase Revenue by Region: 2019-2030
3.3.1 Global Recombinant Glucocerebrosidase Revenue by Region: 2019-2024
3.3.2 Global Recombinant Glucocerebrosidase Revenue by Region: 2025-2030
3.4 North America Recombinant Glucocerebrosidase Market Facts & Figures by Country
3.4.1 North America Recombinant Glucocerebrosidase Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Glucocerebrosidase Sales by Country (2019-2030)
3.4.3 North America Recombinant Glucocerebrosidase Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Glucocerebrosidase Market Facts & Figures by Country
3.5.1 Europe Recombinant Glucocerebrosidase Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Glucocerebrosidase Sales by Country (2019-2030)
3.5.3 Europe Recombinant Glucocerebrosidase Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Glucocerebrosidase Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Glucocerebrosidase Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Glucocerebrosidase Sales by Region (2019-2030)
3.6.3 Asia Pacific Recombinant Glucocerebrosidase Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Glucocerebrosidase Market Facts & Figures by Country
3.7.1 Latin America Recombinant Glucocerebrosidase Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Glucocerebrosidase Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Glucocerebrosidase Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Glucocerebrosidase Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Glucocerebrosidase Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Glucocerebrosidase Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Glucocerebrosidase Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Glucocerebrosidase Sales by Type (2019-2030)
4.1.1 Global Recombinant Glucocerebrosidase Sales by Type (2019-2024)
4.1.2 Global Recombinant Glucocerebrosidase Sales by Type (2025-2030)
4.1.3 Global Recombinant Glucocerebrosidase Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Glucocerebrosidase Revenue by Type (2019-2030)
4.2.1 Global Recombinant Glucocerebrosidase Revenue by Type (2019-2024)
4.2.2 Global Recombinant Glucocerebrosidase Revenue by Type (2025-2030)
4.2.3 Global Recombinant Glucocerebrosidase Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Glucocerebrosidase Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Glucocerebrosidase Sales by Application (2019-2030)
5.1.1 Global Recombinant Glucocerebrosidase Sales by Application (2019-2024)
5.1.2 Global Recombinant Glucocerebrosidase Sales by Application (2025-2030)
5.1.3 Global Recombinant Glucocerebrosidase Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Glucocerebrosidase Revenue by Application (2019-2030)
5.2.1 Global Recombinant Glucocerebrosidase Revenue by Application (2019-2024)
5.2.2 Global Recombinant Glucocerebrosidase Revenue by Application (2025-2030)
5.2.3 Global Recombinant Glucocerebrosidase Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Glucocerebrosidase Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Recombinant Glucocerebrosidase Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Recombinant Glucocerebrosidase Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Takeda Pharmaceuticals
6.2.1 Takeda Pharmaceuticals Company Information
6.2.2 Takeda Pharmaceuticals Description and Business Overview
6.2.3 Takeda Pharmaceuticals Recombinant Glucocerebrosidase Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Takeda Pharmaceuticals Recombinant Glucocerebrosidase Product Portfolio
6.2.5 Takeda Pharmaceuticals Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Recombinant Glucocerebrosidase Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Recombinant Glucocerebrosidase Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 ISU Abxis
6.4.1 ISU Abxis Company Information
6.4.2 ISU Abxis Description and Business Overview
6.4.3 ISU Abxis Recombinant Glucocerebrosidase Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ISU Abxis Recombinant Glucocerebrosidase Product Portfolio
6.4.5 ISU Abxis Recent Developments/Updates
6.5 Protalix Biotherapeutics
6.5.1 Protalix Biotherapeutics Company Information
6.5.2 Protalix Biotherapeutics Description and Business Overview
6.5.3 Protalix Biotherapeutics Recombinant Glucocerebrosidase Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Protalix Biotherapeutics Recombinant Glucocerebrosidase Product Portfolio
6.5.5 Protalix Biotherapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Glucocerebrosidase Industry Chain Analysis
7.2 Recombinant Glucocerebrosidase Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Glucocerebrosidase Production Mode & Process
7.4 Recombinant Glucocerebrosidase Sales and Marketing
7.4.1 Recombinant Glucocerebrosidase Sales Channels
7.4.2 Recombinant Glucocerebrosidase Distributors
7.5 Recombinant Glucocerebrosidase Customers
8 Recombinant Glucocerebrosidase Market Dynamics
8.1 Recombinant Glucocerebrosidase Industry Trends
8.2 Recombinant Glucocerebrosidase Market Drivers
8.3 Recombinant Glucocerebrosidase Market Challenges
8.4 Recombinant Glucocerebrosidase Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Takeda Pharmaceuticals
Sanofi
ISU ABXIS
Protalix Biotherapeutics
List of Tables
 Table 1. Global Recombinant Glucocerebrosidase Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Recombinant Glucocerebrosidase Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Recombinant Glucocerebrosidase Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Recombinant Glucocerebrosidase Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Recombinant Glucocerebrosidase Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Recombinant Glucocerebrosidase Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Recombinant Glucocerebrosidase Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Recombinant Glucocerebrosidase Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Recombinant Glucocerebrosidase, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Glucocerebrosidase, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Glucocerebrosidase, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Glucocerebrosidase, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Glucocerebrosidase by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Glucocerebrosidase as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Glucocerebrosidase Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Recombinant Glucocerebrosidase Sales by Region (2019-2024) & (K Units)
 Table 18. Global Recombinant Glucocerebrosidase Sales Market Share by Region (2019-2024)
 Table 19. Global Recombinant Glucocerebrosidase Sales by Region (2025-2030) & (K Units)
 Table 20. Global Recombinant Glucocerebrosidase Sales Market Share by Region (2025-2030)
 Table 21. Global Recombinant Glucocerebrosidase Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Recombinant Glucocerebrosidase Revenue Market Share by Region (2019-2024)
 Table 23. Global Recombinant Glucocerebrosidase Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Recombinant Glucocerebrosidase Revenue Market Share by Region (2025-2030)
 Table 25. North America Recombinant Glucocerebrosidase Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Recombinant Glucocerebrosidase Sales by Country (2019-2024) & (K Units)
 Table 27. North America Recombinant Glucocerebrosidase Sales by Country (2025-2030) & (K Units)
 Table 28. North America Recombinant Glucocerebrosidase Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Recombinant Glucocerebrosidase Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Recombinant Glucocerebrosidase Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Recombinant Glucocerebrosidase Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Recombinant Glucocerebrosidase Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Recombinant Glucocerebrosidase Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Recombinant Glucocerebrosidase Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Recombinant Glucocerebrosidase Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Recombinant Glucocerebrosidase Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Recombinant Glucocerebrosidase Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Recombinant Glucocerebrosidase Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Recombinant Glucocerebrosidase Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Recombinant Glucocerebrosidase Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Recombinant Glucocerebrosidase Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Recombinant Glucocerebrosidase Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Recombinant Glucocerebrosidase Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Recombinant Glucocerebrosidase Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Recombinant Glucocerebrosidase Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Recombinant Glucocerebrosidase Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Recombinant Glucocerebrosidase Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Recombinant Glucocerebrosidase Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Glucocerebrosidase Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Recombinant Glucocerebrosidase Sales (K Units) by Type (2019-2024)
 Table 51. Global Recombinant Glucocerebrosidase Sales (K Units) by Type (2025-2030)
 Table 52. Global Recombinant Glucocerebrosidase Sales Market Share by Type (2019-2024)
 Table 53. Global Recombinant Glucocerebrosidase Sales Market Share by Type (2025-2030)
 Table 54. Global Recombinant Glucocerebrosidase Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Recombinant Glucocerebrosidase Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Recombinant Glucocerebrosidase Revenue Market Share by Type (2019-2024)
 Table 57. Global Recombinant Glucocerebrosidase Revenue Market Share by Type (2025-2030)
 Table 58. Global Recombinant Glucocerebrosidase Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Recombinant Glucocerebrosidase Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Recombinant Glucocerebrosidase Sales (K Units) by Application (2019-2024)
 Table 61. Global Recombinant Glucocerebrosidase Sales (K Units) by Application (2025-2030)
 Table 62. Global Recombinant Glucocerebrosidase Sales Market Share by Application (2019-2024)
 Table 63. Global Recombinant Glucocerebrosidase Sales Market Share by Application (2025-2030)
 Table 64. Global Recombinant Glucocerebrosidase Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Recombinant Glucocerebrosidase Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Recombinant Glucocerebrosidase Revenue Market Share by Application (2019-2024)
 Table 67. Global Recombinant Glucocerebrosidase Revenue Market Share by Application (2025-2030)
 Table 68. Global Recombinant Glucocerebrosidase Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Recombinant Glucocerebrosidase Price (US$/Unit) by Application (2025-2030)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Recombinant Glucocerebrosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Pfizer Recombinant Glucocerebrosidase Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Takeda Pharmaceuticals Company Information
 Table 76. Takeda Pharmaceuticals Description and Business Overview
 Table 77. Takeda Pharmaceuticals Recombinant Glucocerebrosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Takeda Pharmaceuticals Recombinant Glucocerebrosidase Product
 Table 79. Takeda Pharmaceuticals Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Recombinant Glucocerebrosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Sanofi Recombinant Glucocerebrosidase Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. ISU Abxis Company Information
 Table 86. ISU Abxis Description and Business Overview
 Table 87. ISU Abxis Recombinant Glucocerebrosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. ISU Abxis Recombinant Glucocerebrosidase Product
 Table 89. ISU Abxis Recent Developments/Updates
 Table 90. Protalix Biotherapeutics Company Information
 Table 91. Protalix Biotherapeutics Description and Business Overview
 Table 92. Protalix Biotherapeutics Recombinant Glucocerebrosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Protalix Biotherapeutics Recombinant Glucocerebrosidase Product
 Table 94. Protalix Biotherapeutics Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Recombinant Glucocerebrosidase Distributors List
 Table 98. Recombinant Glucocerebrosidase Customers List
 Table 99. Recombinant Glucocerebrosidase Market Trends
 Table 100. Recombinant Glucocerebrosidase Market Drivers
 Table 101. Recombinant Glucocerebrosidase Market Challenges
 Table 102. Recombinant Glucocerebrosidase Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Glucocerebrosidase
 Figure 2. Global Recombinant Glucocerebrosidase Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Recombinant Glucocerebrosidase Market Share by Type: 2023 & 2030
 Figure 4. Imiglucerase Product Picture
 Figure 5. Velaglucerase Alfa Product Picture
 Figure 6. Taliglucerase Alfa Product Picture
 Figure 7. Global Recombinant Glucocerebrosidase Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Recombinant Glucocerebrosidase Market Share by Application: 2023 & 2030
 Figure 9. Hospital and Clinic
 Figure 10. Pharmacy
 Figure 11. Other
 Figure 12. Global Recombinant Glucocerebrosidase Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Recombinant Glucocerebrosidase Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Recombinant Glucocerebrosidase Sales (2019-2030) & (K Units)
 Figure 15. Global Recombinant Glucocerebrosidase Average Price (US$/Unit) & (2019-2030)
 Figure 16. Recombinant Glucocerebrosidase Report Years Considered
 Figure 17. Recombinant Glucocerebrosidase Sales Share by Manufacturers in 2023
 Figure 18. Global Recombinant Glucocerebrosidase Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Recombinant Glucocerebrosidase Players: Market Share by Revenue in Recombinant Glucocerebrosidase in 2023
 Figure 20. Recombinant Glucocerebrosidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Recombinant Glucocerebrosidase Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Recombinant Glucocerebrosidase Sales Market Share by Country (2019-2030)
 Figure 23. North America Recombinant Glucocerebrosidase Revenue Market Share by Country (2019-2030)
 Figure 24. United States Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Recombinant Glucocerebrosidase Sales Market Share by Country (2019-2030)
 Figure 27. Europe Recombinant Glucocerebrosidase Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Recombinant Glucocerebrosidase Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Recombinant Glucocerebrosidase Revenue Market Share by Region (2019-2030)
 Figure 35. China Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Recombinant Glucocerebrosidase Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Recombinant Glucocerebrosidase Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Recombinant Glucocerebrosidase Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Recombinant Glucocerebrosidase Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Recombinant Glucocerebrosidase by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Recombinant Glucocerebrosidase by Type (2019-2030)
 Figure 54. Global Recombinant Glucocerebrosidase Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Recombinant Glucocerebrosidase by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Recombinant Glucocerebrosidase by Application (2019-2030)
 Figure 57. Global Recombinant Glucocerebrosidase Price (US$/Unit) by Application (2019-2030)
 Figure 58. Recombinant Glucocerebrosidase Value Chain
 Figure 59. Recombinant Glucocerebrosidase Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Velaglucerase Alfa Market Research Report 2024
Global Enzyme Replacement Therapy Drugs for Gaucher Disease Market Research Report 2024
Global Type 1 Gaucher Disease Treatment Market Research Report 2024
Global Gaucher Disease GD Drugs Market Insights Forecast to 2030
Global Gaucher s Disease Oral Therapy Market Research Report 2024
Global Substrate Inhibition Therapy of Gaucher Disease Market Research Report 2024
Gaucher s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Therapeutic Recombinant Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gaucher Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gaucher Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Recombinant Protein Market Research Report 2024
Gaucher and Pompe Diseases Enzyme Replacement Therapy ERT Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gaucher and Pompe Diseases Enzyme Replacement Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lysosomal Storage Disease Treatment Market Research Report 2024
Global Recombinant Therapeutic Protein Market Research Report 2025
Global Recombinant Uricase Market Research Report 2024
Recombinant DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rare Disease Enzyme Replacement Therapy Drugs Market Research Report 2024
Global Recombinant Antibody Market Research Report 2025
Global β Glucosidase Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions